vaccine research afp
We Care...!!!

The “monoclonal neutralising antibody” developed at the Israel Institute for Biological Research (IIBR) “can neutralise it (the disease-causing coronavirus) inside carriers’ bodies,” Defence Minister Naftali Bennett said.

JERUSALEM: Israel has isolated a key coronavirus antibody at its main biological research laboratory, the Israeli defence minister said on Monday, calling the step a “significant breakthrough” toward a possible treatment for the coronavirus pandemic.

The “monoclonal neutralising antibody” developed at the Israel Institute for Biological Research (IIBR) “can neutralise it (the disease-causing coronavirus) inside carriers’ bodies,” Defence Minister Naftali Bennett said in a statement.

The statement added that Naftali Bennett visited the Israel Institute for Biological Research on Monday where he was briefed “on a significant breakthrough in finding an antidote for the coronavirus”.

It quoted IIBR Director Shmuel Shapira as saying that the antibody formula was being patented, after which an international manufacturer would be sought to mass-produce it.

The IIBR has been leading Israeli efforts to develop a treatment and vaccine for the coronavirus, including  the testing of blood from those who recovered from COVID-19, the respiratory disease caused by the virus.

Antibodies in such samples – immune-system proteins that are residues of successfully overcoming the coronavirus – are widely seen as a key to developing a possible cure

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »